VRPXVirpax Pharmaceuticals, Inc.

Nasdaq virpaxpharma.com


$ 1.17 $ 0.44 (59.71 %)    

Monday, 08-Jul-2024 11:10:09 EDT
QQQ $ 496.42 $ -0.11 (-0.02 %)
DIA $ 395.27 $ 0.86 (0.22 %)
SPY $ 555.40 $ 0.49 (0.09 %)
TLT $ 92.52 $ 0.08 (0.09 %)
GLD $ 219.52 $ -0.12 (-0.05 %)
$ 0.578
$ 0.73
$ 1.15 x 200
$ 1.17 x 200
$ 0.67 - $ 1.35
$ 0.46 - $ 10.80
54,921
na
676,973
$ 0.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 12-07-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-downgrades-virpax-pharmaceuticals-to-hold

Maxim Group analyst Naz Rahman downgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Buy to Hold.

 virpax-announces-pricing-of-225m-public-offering

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing n...